Viewing Study NCT07310420


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-30 @ 12:14 AM
Study NCT ID: NCT07310420
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-11
First Post: 2025-12-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer
Sponsor: TerSera Therapeutics LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module